MUSTANG BIO, INC. Other Receivables, Net, Current
MUSTANG BIO, INC. (MBIO) had Other Receivables, Net, Current of $217.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Nontrade Receivables
us-gaap:OtherReceivablesNetCurrent · last filed 2026-08-05
- 2026-06-30: Other Receivables, Net, Current $217.00K.
- 2026-03-31: Other Receivables, Net, Current $217.00K.
- 2025-12-31: Other Receivables, Net, Current $217.00K.
- 2024-12-31: Other Receivables, Net, Current $402.00K.
| Period end | Other Receivables, Net, Current |
|---|---|
| 2026-06-30 | $217.00K 10-Q · filed 2026-08-05 |
| 2026-03-31 | $217.00K 10-Q · filed 2026-05-05 |
| 2025-12-31 | $217.00K 10-Q · filed 2026-08-05 |
| 2024-12-31 | $402.00K 10-K · filed 2026-03-19 |
| 2018-09-30 | $50.00K 10-Q · filed 2018-11-13 |
| 2017-12-31 | $0.00 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |